Clark AS - Search Results

1

Breast Cancer ¹⁸F-ISO-1 Uptake as a Marker of Proliferation Status.

McDonald ES, Doot RK, Young AJ, Schubert EK, Tchou J, Pryma DA, Farwell MD, Nayak A, Ziober A, Feldman MD, DeMichele A, Clark AS, Shah PD, Lee H, Carlin SD, Mach RH, Mankoff DA. McDonald ES, et al. Among authors: clark as. J Nucl Med. 2020 May;61(5):665-670. doi: 10.2967/jnumed.119.232363. Epub 2019 Dec 13. J Nucl Med. 2020. PMID: 31836680 Free PMC article.

2

Molecular imaging biomarkers for oncology clinical trials.

Mankoff DA, Pryma DA, Clark AS. Mankoff DA, et al. Among authors: clark as. J Nucl Med. 2014 Apr;55(4):525-8. doi: 10.2967/jnumed.113.126128. Epub 2014 Mar 10. J Nucl Med. 2014. PMID: 24614222 Free article. Review.

3

Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657).

Clark AS, Chen J, Kapoor S, Friedman C, Mies C, Esserman L, DeMichele A; I-SPY1 Investigators. Clark AS, et al. Cancer Med. 2014 Jun;3(3):693-701. doi: 10.1002/cam4.235. Epub 2014 Apr 9. Cancer Med. 2014. PMID: 24719175 Free PMC article. Clinical Trial.

4

Using nuclear medicine imaging in clinical practice: update on PET to guide treatment of patients with metastatic breast cancer.

Clark AS, McDonald E, Lynch MC, Mankoff D. Clark AS, et al. Oncology (Williston Park). 2014 May;28(5):424-30. Oncology (Williston Park). 2014. PMID: 25004657 Free article. Review.

5

CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment.

DeMichele A, Clark AS, Tan KS, Heitjan DF, Gramlich K, Gallagher M, Lal P, Feldman M, Zhang P, Colameco C, Lewis D, Langer M, Goodman N, Domchek S, Gogineni K, Rosen M, Fox K, O'Dwyer P. DeMichele A, et al. Among authors: clark as. Clin Cancer Res. 2015 Mar 1;21(5):995-1001. doi: 10.1158/1078-0432.CCR-14-2258. Epub 2014 Dec 11. Clin Cancer Res. 2015. PMID: 25501126 Clinical Trial.

6

How Imaging Can Impact Clinical Trial Design: Molecular Imaging as a Biomarker for Targeted Cancer Therapy.

Mankoff DA, Farwell MD, Clark AS, Pryma DA. Mankoff DA, et al. Among authors: clark as. Cancer J. 2015 May-Jun;21(3):218-24. doi: 10.1097/PPO.0000000000000116. Cancer J. 2015. PMID: 26049702 Review.

7

How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.

Farwell MD, Clark AS, Mankoff DA. Farwell MD, et al. Among authors: clark as. JAMA Oncol. 2015 Jul;1(4):421-2. doi: 10.1001/jamaoncol.2015.0667. JAMA Oncol. 2015. PMID: 26181243 No abstract available.

8

Palbociclib (PD0332991)-a Selective and Potent Cyclin-Dependent Kinase Inhibitor: A Review of Pharmacodynamics and Clinical Development.

Clark AS, Karasic TB, DeMichele A, Vaughn DJ, O'Hara M, Perini R, Zhang P, Lal P, Feldman M, Gallagher M, O'Dwyer PJ. Clark AS, et al. JAMA Oncol. 2016 Feb;2(2):253-60. doi: 10.1001/jamaoncol.2015.4701. JAMA Oncol. 2016. PMID: 26633733 Review.

9

HER2 imaging in the ZEPHIR study.

Clark AS, DeMichele A, Mankoff D. Clark AS, et al. Ann Oncol. 2016 Apr;27(4):555-7. doi: 10.1093/annonc/mdw033. Epub 2016 Jan 22. Ann Oncol. 2016. PMID: 26802154 Free article. No abstract available.

10

Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer.

Fowler AM, Clark AS, Katzenellenbogen JA, Linden HM, Dehdashti F. Fowler AM, et al. Among authors: clark as. J Nucl Med. 2016 Feb;57 Suppl 1(Suppl 1):75S-80S. doi: 10.2967/jnumed.115.157933. J Nucl Med. 2016. PMID: 26834106 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters